Ziad Mallat1, Alain Tedgui. 1. INSERM U541, Circulation Paris VII Institut Fédératif de Recherche, Hôpital Lariboisière, 41 Boulevard de la Chapelle, 75010 Paris, France. ziad.mallat@inserm.lrb.ap-hop-paris.fr
Abstract
PURPOSE OF REVIEW: Atherosclerosis is a disease of the arterial wall that seems to be tightly modulated by the local inflammatory balance. Transforming growth factors beta 1, 2 and 3 are cytokines/growth factors with broad activities on cells and tissues in the cardiovascular system, and have been suggested to play a role in the pathogenesis of atherosclerosis. RECENT FINDINGS: In the present review, we discuss recent developments in the role of transforming growth factor beta in the regulation of the immuno-inflammatory balance that modulates atherosclerosis. Such studies strongly suggest that the inhibition of endogenous transforming growth factor beta signalling favours the development of atherosclerotic lesions with an increased inflammatory component (T cells and macrophages) and decreased collagen content, features that are characteristic of unstable atherosclerotic plaques. SUMMARY: Transforming growth factor beta is identified as a critical modulator of the immuno-inflammatory balance in atherosclerosis, and a crucial plaque-stabilizing factor. Future studies should aim at defining the precise molecular mechanisms responsible for this protective effect, and developing immunomodulatory strategies based on the promotion of transforming growth factor beta activity (T regulatory T helper type 3 cells) to limit disease complications.
PURPOSE OF REVIEW: Atherosclerosis is a disease of the arterial wall that seems to be tightly modulated by the local inflammatory balance. Transforming growth factors beta 1, 2 and 3 are cytokines/growth factors with broad activities on cells and tissues in the cardiovascular system, and have been suggested to play a role in the pathogenesis of atherosclerosis. RECENT FINDINGS: In the present review, we discuss recent developments in the role of transforming growth factor beta in the regulation of the immuno-inflammatory balance that modulates atherosclerosis. Such studies strongly suggest that the inhibition of endogenous transforming growth factor beta signalling favours the development of atherosclerotic lesions with an increased inflammatory component (T cells and macrophages) and decreased collagen content, features that are characteristic of unstable atherosclerotic plaques. SUMMARY:Transforming growth factor beta is identified as a critical modulator of the immuno-inflammatory balance in atherosclerosis, and a crucial plaque-stabilizing factor. Future studies should aim at defining the precise molecular mechanisms responsible for this protective effect, and developing immunomodulatory strategies based on the promotion of transforming growth factor beta activity (T regulatory T helper type 3 cells) to limit disease complications.
Authors: De-xiu Bu; Vivek Rai; Xiaoping Shen; Rosa Rosario; Yan Lu; Vivette D'Agati; Shi Fang Yan; Richard A Friedman; Edem Nuglozeh; Ann Marie Schmidt Journal: Circ Res Date: 2010-02-04 Impact factor: 17.367
Authors: Anna-Karin L Robertson; Mats Rudling; Xinghua Zhou; Leonid Gorelik; Richard A Flavell; Göran K Hansson Journal: J Clin Invest Date: 2003-10-20 Impact factor: 14.808
Authors: Michelle Jackson; Yasmeen Ahmad; Ian N Bruce; Beatrice Coupes; Paul E C Brenchley Journal: Arthritis Res Ther Date: 2006-04-28 Impact factor: 5.156